A federal appeals court has dealt another setback to a Maryland law aimed at limiting price spikes for generic drugs.
The 4th Circuit Court of Appeals on Tuesday denied the request of Maryland Attorney General Brian E. Frosh for a re-hearing of a challenge to the law before the full court.
A three-judge panel from the 4th Circuit ruled in April that the law, approved by state lawmakers in 2017, was unconstitutional.
The law gave the attorney general the authority to review price information about generic drugs. If the state’s lawyers could show that prices were being raised too steeply, they could seek to order the prices reduced, or issue fines to the drug...